NextDocs, a Conshohocken, Pa.-based provider of regulated content management and compliance solutions for the life sciences industry, has joined the Parexel Perceptive Partner Program. NextDocs will enhance and broaden its services to biopharmaceutical customers by leveraging the Perceptive MyTrials eClinical platform, a suite of applications for managing clinical trials.
Both NextDocs and Parexel Informatics have entered into an integration agreement that will strengthen the offerings of both organizations. NextDocs will utilize its open and extensible architecture to integrate with the Perceptive suite of technology solutions, specifically Impact CTMS and Liquent InSight
"Through the NextDocs/ Parexel Informatics integration partnership, our mutual clients are anticipated to benefit from the sharing of critical metadata and documents among Impact CTMS, Liquent InSight and NextDocs, giving them improved access to vital eClinical metrics," said Graham Bunn, vice president, Perceptive Partner Program. "The expected result is an improvement in decision-making capabilities and a reduction in the manual processes for our clients."
With its market-leading NextDocs 6 eTMF solution and Investigator Portal offering called Trial Exchange (TrX), NextDocs currently manages over one million regulatory documents for over 500 clinical trials. The Perceptive MyTrials suites of applications allows partners to integrate targeted, specialized solutions within the platform. This gives their sponsors efficient access to clinical data and applications from a single source, with the aim of allowing them to more efficiently and effectively manage critical trial activities.